Trial intelligence / Profile preview

Ultrasound Microbubbles and Chemotherapy for Liver Metastases and Pancreatic Carcinoma

NCT02233205Phase 2Unknown

Sponsor
Peking University Cancer Hospital & Institute
Start
Oct 2014
Primary completion
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sulfur hexafluoride in liver metastases, pancreatic carcinoma, sponsored by Peking University Cancer Hospital & Institute. Status: unknown.

02

Drugs

sulfur hexafluoride
03

Conditions

liver metastasespancreatic carcinoma

Beyond the preview

Go deeper on NCT02233205.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02233205.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call